Loading Events
February 16, 2017, 11:30 am - 1:00 pm

Global Health: How China Impacts The World

The Boathouse at Confluence Park

679 West Spring Street, Columbus, OH 43215

Speaker: Dr. Yanzhong Huang, Dr. Desmond Thio

As the world becomes ever more interconnected, health issues in one part of the globe often impact people and communities in another part. Whether it is the global transmission of diseases – such as SARS, Ebola, and Zika – or the United Nations’ establishment of the Sustainable Development Goals adopted a year ago, it is no longer in question that global health challenges require global solutions.  Moreover, individual countries can no longer afford to address their domestic public health crises through a purely domestic lens.

China’s rise as a global power has attracted much attention, from economists, policymakers, human rights advocates, and yes, from public health professionals.  Even as China has increased its public health aid to other parts of the world, notably in Africa and Latin America, it continues to face challenges on its home front that have ripple effects.  China’s economic growth has come at social costs; the increasing prevalence of pollution has at times forced municipalities to close schools and airports, limit road traffic, and suspend manufacturing.  Longer term, pollution impacts life expectancy, child development and fosters chronic and terminal diseases, all of which directly influence China’s prospects for economic growth.  In September, China released its national strategy for implementing the UN’s 2030 Agenda for Sustainable Development.  As the world’s second leading economy, the world will be watching China to determine how it simultaneously manages growth and an array of public health concerns.

Join us for a compelling dialogue on February 16, 2017 with Dr. Yanzhong Huang and Dr. Desmond Thio about the intersections between health, climate change, environment, and economic interests, with a particular focus on these issues in the Chinese context.  As China grapples with these challenges, what are the implications for the United States and the rest of the world?

Sponsors

Dr. Yanzhong Huang

Senior Fellow for Global Health

Council on Foreign Relations

Dr. Yanzhong Huang is senior fellow for global health at the Council on Foreign Relations, where he directs the Global Health Governance roundtable. He is also professor and director of global health studies at Seton Hall University’s School of Diplomacy and International Relations, where he developed the first academic concentration among U.S. professional schools of international affairs that explicitly addresses the security and foreign policy aspects of health issues. He is the founding editor of Global Health Governance: The Scholarly Journal for the New Health Security Paradigm. Huang has written extensively on global health governance, health diplomacy and health security, and public health in China and East Asia. He has published numerous reports, journal articles, and book chapters, and in 2006, he coauthored the first scholarly article that systematically examined China’s soft power. His book Governing Health in Contemporary China looks at health-care reform, government ability to address disease outbreaks, and food and drug safety in China.

Dr. Desmond Thio

DeltaHealth China CEO

DeltaHealth China

Dr. Desmond Thio is the CEO of DeltaHealth China. He holds a diploma in Electrical Engineering and Bachelor degree of Science in Mathematics from Dalhousie University. He received a Doctor’s degree in Medicine from Mundial University in 1986. He also holds a Master’s degree of Science in Preventive Medicine from Ohio State University and an MBA from University of South Australia. He recently received his PhD/DBA from University Versailles/INSEEC in Applied Economics with focus on China private healthcare system. Prior to joining DeltaHealth China, Dr. Thio was the president and senior vice president of Healthcare Greater China of Philips, being responsible for strategic planning, business development and overall management. He was a senior executive in a number of global and regional pharmaceutical and medical device companies based in Hong Kong, Taiwan, Japan and the USA.